Morgan Jess S & CO Inc Biond Vax Pharmaceuticals Ltd. Transaction History

Morgan Jess S & CO Inc

  • $115 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Nov 30, 2021
SELL
$2.5 - $40.97 $186,160 - $3.05 Million
-74,464 Closed
0 $0
Q3 2020

Nov 29, 2021
BUY
$23.7 - $51.1 $97,596 - $210,429
4,118 Added 5.85%
74,464 $2.91 Million
Q2 2020

Nov 29, 2021
BUY
$7.2 - $24.87 $506,491 - $1.75 Million
70,346 New
70,346 $1.6 Million

About BiondVax Pharmaceuticals Ltd.

BVXV Quotes by TradingView
  • Ticker BVXV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,678,800
  • Market Cap $12M
  • Description
  • BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...
More about BVXV
Track This Portfolio

Track Morgan Jess S & CO Inc Portfolio

Follow Morgan Jess S & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Jess S & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Jess S & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email